CytoVeris Revenue and Competitors

Farmington, CT USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • CytoVeris's estimated annual revenue is currently $6M per year.(i)
  • CytoVeris's estimated revenue per employee is $251,000

Employee Data

  • CytoVeris has 24 Employees.(i)
  • CytoVeris grew their employee count by -23% last year.

CytoVeris's People

NameTitleEmail/Phone
1
VP EngineeringReveal Email/Phone
2
Senior EngineerReveal Email/Phone
3
President & CEOReveal Email/Phone
4
Biomedical EngineerReveal Email/Phone
5
Administrative AssociateReveal Email/Phone
6
Machine learning data scientistReveal Email/Phone
7
Administrative AssociateReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$30.6M1224%N/AN/A
#2
$31.6M126-4%N/AN/A
#3
$17.8M710%N/AN/A
#4
$8.5M34-8%N/AN/A
#5
$5M20-31%N/AN/A
#6
$36.6M1468%N/AN/A
#7
$7.3M294%N/AN/A
#8
$6.8M270%N/AN/A
#9
$543.2M21643%N/AN/A
#10
$0.3M1-90%N/AN/A
Add Company

What Is CytoVeris?

CytoVeris has been founded with the vision to develop new optical based ‘guided surgery' probes to allow surgical oncologists to identify and remove all tumor tissue in real-time during cancer resection surgery, thereby improving the surgeon's ability to ensure clean margins are attained. We are developing technology to detect molecular signatures that cancer cells create due to the way that they hijack the cellular metabolic processes and corrupt DNA and protein pathways which creates signature variations of molecules such as lipids, proteins and metabolites that can be detected via our OncoMap system.

keywords:N/A

N/A

Total Funding

24

Number of Employees

$6M

Revenue (est)

-23%

Employee Growth %

N/A

Valuation

N/A

Accelerator

CytoVeris News

2022-04-06 - Primary radiotherapy and deep inferior epigastric perforator ...

Declaration of interests. PTRT reports personal fees from Stryker Surgical and Cytoveris. DRL is an advisory board member for CMR Surgical. JEH...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.7M27-37%N/A
#2
$2.3M27-13%N/A
#3
$4.9M28N/AN/A
#4
$7.5M28-18%N/A
#5
$2.9M28-10%N/A